Exemestane synthesis
- Product Name:Exemestane
- CAS Number:107868-30-4
- Molecular formula:C20H24O2
- Molecular Weight:296.4
19457-55-7
128 suppliers
$46.00/1g
107868-30-4
531 suppliers
$28.00/5mg
Yield:107868-30-4 81.8%
Reaction Conditions:
with N,O-Bis(trimethylsilyl)trifluoroacetamide;chloranil;trifluorormethanesulfonic acid in toluene at 108 - 110; for 0.75 h;Product distribution / selectivity;Heating / reflux;
Steps:
1
EXAMPLE 1 Obtaining 6-methylenandrost-1,4-dien-3,17-dione; [Show Image] A mixture of 1 g of 6-methylenandrost-4-en-3,17-dione (3.5 mmol), 0.91 g of 2,3,5,6-tetrachloro-1,4-benzoquinone (chloranil) (3.7 mmol), 80 ml of toluene, 0.03 ml of trifluoromethanesulfonic acid (0.35 mmol) and 3.74 ml of bis(trimethylsilyl)trifluoroacetamide (BSTFA) (14.1 mmol) is stirred at reflux temperature (about 108-110°C) for 45 minutes. The mixture is then cooled at room temperature (20-22°C) and washed 6 times with a 2% aqueous sodium hydroxide solution (20 ml each time) and 3 times with a 30% aqueous sodium chloride solution. The organic phase is evaporated under reduced pressure, the solvent is substituted with heptane and the suspension is cooled. The product is filtered, washed with cold heptane and dried, obtaining 0.81 g [Yield : 81.8%] of crude 6-methylenandrost-1,4-dien-3,17-dione. The product can be purified by recrystallization in solvents or mixtures of solvents (ethyl acetate, ethyl acetate/heptane, ethanol or ethanol/water). The recrystallized solid has a melting point (m.p.) of 191-194°C and the following spectroscopic characteristics: 1H-NMR (DMSO-d6) : 0.83 (3H, s, CH3 18), 1.09 (3H, s, CH3 19), 1.30-1.80 (10 H), 1.99 (1H, dt, J 9.6; 18.8 Hz, H16), 2.39 (1H, dd, J 8.8; 18.8 Hz, H16), 5.01 (2H, s, H 6a), 5.96 (1H, s, H4), 6.12 (1H, d, J 10.0 Hz, H2), 7.22 (1H, d, J 10.0 Hz, H1). 13C-NMR (DMSO-d6): 14.1 (CH3 18), 20.1 (CH3 19), 22.0 (CH2), 22.2 (CH2), 31.5 (CH2), 35.3 (CH), 35.9 (CH2), 39.2 (CH2), 44.1 (C 13), 47.7 (C 10), 49.9 (CH), 50.3 (CH), 112.8 (C 6 a), 122.4 (C4), 127.6 (C3), 146.1 (C5), 155.8 (C1), 168.2 (C6), 185.7 (C3), 219.7 (C17).
References:
Crystal Pharma, S.A. EP2070943, 2009, A1 Location in patent:Page/Page column 9
933455-74-4
0 suppliers
inquiry
107868-30-4
531 suppliers
$28.00/5mg
861395-77-9
9 suppliers
inquiry
107868-30-4
531 suppliers
$28.00/5mg
122370-91-6
62 suppliers
$215.00/1mg
107868-30-4
531 suppliers
$28.00/5mg
7440-44-0
308 suppliers
$12.00/25g
19457-55-7
128 suppliers
$46.00/1g
75-65-0
752 suppliers
$10.00/10ml
107868-30-4
531 suppliers
$28.00/5mg